[{"AccountsPayableCurrent_0_Q3_USD":3861000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":796000.0,"OtherLiabilitiesCurrent_0_Q3_USD":628000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-146000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-89000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":-89000.0,"OtherAssetsNoncurrent_0_Q3_USD":3294000.0,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q3_USD":796000.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q3_USD":5337000.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q3_USD":5469000.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_Q3_USD":4996000.0,"OperatingLeasesFutureMinimumPaymentsDueInFiveYears_0_Q3_USD":1732000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_1_Q3_USD":0.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q3_USD":18330000.0,"OperatingLeaseExpense_1_Q3_USD":900000.0,"OperatingIncomeLoss_3_Q3_USD":-79933000.0,"OperatingIncomeLoss_1_Q3_USD":-28997000.0,"OperatingExpenses_3_Q3_USD":102287000.0,"OperatingExpenses_1_Q3_USD":39249000.0,"NetIncomeLoss_1_Q3_USD":-28835000.0,"NetIncomeLoss_3_Q3_USD":-79492000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-53454000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-71728000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":153382000.0,"LongTermInvestments_0_Q3_USD":121480000.0,"OperatingLeaseExpense_3_Q3_USD":2600000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_3_Q3_USD":0.0,"PaymentsToAcquireInvestments_3_Q3_USD":257813000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":4799000.0,"TaxesPayableCurrent_0_Q3_USD":37000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":584000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":1017000.0,"StockholdersEquity_0_Q3_USD":375217000.0,"ShortTermInvestments_0_Q3_USD":196458000.0,"ShareBasedCompensation_3_Q3_USD":10957000.0,"SecurityDeposit_0_Q3_USD":91000.0,"Revenues_3_Q3_USD":22354000.0,"Revenues_1_Q3_USD":10252000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-183190000.0,"RestrictedCashNoncurrent_0_Q3_USD":286000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":79903000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":30906000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":9569000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":23692000.0,"ProfitLoss_3_Q3_USD":-79492000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":1166000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_3_Q3_USD":183890000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":150157000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":9343000.0,"PreferredStockValue_0_Q3_USD":null,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"LitigationSettlementExpense_3_Q3_USD":0.0,"LiabilitiesCurrent_0_Q3_USD":50680000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":493074000.0,"Liabilities_0_Q3_USD":117857000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-28924000.0,"CommonStockValue_0_Q3_USD":45000.0,"CommonStockSharesOutstanding_0_Q3_shares":44556604.0,"CommonStockSharesIssued_0_Q3_shares":44556604.0,"CommonStockSharesAuthorized_0_Q3_shares":500000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"CommonStockDividendsPerShareDeclared_3_Q3_USD":0.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":9564073.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":28200000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":147726000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_0_Q3_USD":286000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":147440000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":147440000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":839000.0,"AssetsCurrent_0_Q3_USD":358445000.0,"Assets_0_Q3_USD":493074000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":5732861.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":5732861.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":4313000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":558421000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-59000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":14123000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":1380000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-1100000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-79638000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":42344420.0,"ContractWithCustomerAssetNet_0_Q3_USD":5000000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":66381000.0,"InterestAndOtherIncome_3_Q3_USD":528000.0,"InterestAndOtherIncome_1_Q3_USD":39000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":6040000.0,"IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_3_Q3_USD":2844000.0,"IncreaseDecreaseInIncomeTaxesReceivable_3_Q3_USD":-3642000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":8147000.0,"IncreaseDecreaseInContractWithCustomerAsset_3_Q3_USD":-2500000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":727000.0,"IncomeTaxReceivable_0_Q3_USD":204000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":87000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":-123000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-79405000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-28958000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":22384000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":8343000.0,"GainLossOnDispositionOfAssets_3_Q3_USD":-128000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":54900000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":6000000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.65,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.88,"DepreciationAndAmortization_1_Q3_USD":700000.0,"DepreciationAndAmortization_3_Q3_USD":2033000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_3_Q3_USD":500000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_1_Q3_USD":100000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0_Q3_security":0.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":35250000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":44374389.0,"Ticker":"NRIX","CIK":"1549595","name":"NURIX THERAPEUTICS, INC.","OfficialName":"Nurix Therapeutics Inc. Common stock","form":"10-Q","period":"20210831","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"593342561.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211014"}]